Startseite UR
Einträge von Lauer, Ulrich M. auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 12.
2023
Koch, Jana, Beil, Julia, Berchtold, Susanne, Mönch, Dina, Maaß, Annika, Smirnow, Irina, Schenk, Andrea, Carter, Mary E., Kloker, Linus D., Leibold, Tobias, Renner, Philipp, Dahlke, Marc-H. und Lauer, Ulrich M.
(2023)
Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model.
Viruses 15 (2), S. 363.
Volltext nicht vorhanden.
2022
Mayer, Mascha, Berger, Alexander, Leischner, Christian, Renner, Olga, Burkard, Markus, Böcker, Alexander, Noor, Seema, Weiland, Timo, Weiss, Thomas S. 
, Busch, Christian, Lauer, Ulrich M., Bischoff, Stephan C. und Venturelli, Sascha
(2022)
Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma.
Pharmaceuticals 15 (4), S. 438.
2014
Takimoto, Toru, Zimmermann, Martina, Armeanu-Ebinger, Sorin, Bossow, Sascha, Lampe, Johanna, Smirnow, Irina, Schenk, Andrea , Lange, Sebastian , Weiss, Thomas S., Neubert, Wolfgang, Lauer, Ulrich M. und Bitzer, Michael
(2014)
Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors.
PLoS ONE 9 (3), e90508.
2013
Gaetano, Carlo, Venturelli, Sascha, Berger, Alexander, Böcker, Alexander, Busch, Christian, Weiland, Timo, Noor, Seema, Leischner, Christian, Schleicher, Sabine, Mayer, Mascha , Weiss, Thomas S., Bischoff, Stephan C., Lauer, Ulrich M. und Bitzer, Michael
(2013)
Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells.
PLoS ONE 8 (8), e73097.
2012
Haybaeck, Johannes, Weiland, Timo, Klein, Kathrin, Zimmermann, Martina, Speicher, Tobias, Venturelli, Sascha, Berger, Alexander, Bantel, Heike, Königsrainer, Alfred, Schenk, Martin , Weiss, Thomas S., Wendel, Albrecht, Schwab, Matthias, Bitzer, Michael und Lauer, Ulrich M.
(2012)
Selective Protection of Human Liver Tissue in TNF-Targeting of Cancers of the Liver by Transient Depletion of Adenosine Triphosphate.
PLoS ONE 7 (12), e52496.
Berger, Alexander, Venturelli, Sascha, Kallnischkies, Mascha, Böcker, Alexander, Busch, Christian, Weiland, Timo, Noor, Seema, Leischner, Christian, Weiss, Thomas S. , Lauer, Ulrich M., Bischoff, Stephan C. und Bitzer, Michael
(2012)
Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases.
The Journal of Nutritional Biochemistry 24 (6), S. 977-985.
Volltext nicht vorhanden.
, Lauer, Ulrich M., Bischoff, Stephan C. und Bitzer, Michael
(2012)
Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases.
The Journal of Nutritional Biochemistry 24 (6), S. 977-985.
Volltext nicht vorhanden.
2009
Lauer, Ulrich M., Weiss, Thomas S., Bitzer, Michael, Gregor, Michael, Königsrainer, Alfred, Groothuis, Geny M. M., Rots, Marianne, Wehrmann, Manfred, Wagner, Silvia , Kupka, Susan, Smirnow, Irina, Armeanu-Ebinger, Sorin und Zimmermann, Martina
(2009)
Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses.
International Journal of Oncology 34 (5), S. 1247-1256.
2008
Armeanu-Ebinger, Sorin, Krusch, Matthias, Baltz, Katrin M., Weiss, Thomas S. , Smirnow, Irina, Steinle, Alexander , Lauer, Ulrich M., Bitzer, Michael und Salih, Helmut R.
(2008)
Direct and Natural Killer Cell-Mediated Antitumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma.
Clinical Cancer Research 14 (11), S. 3520-3528.
2007
Venturelli, Sascha, Armeanu, Sorin, Pathil, Anita, Hsieh, Chih‐Jen, Weiss, Thomas S. , Vonthein, Reinhard, Wehrmann, Manfred, Gregor, Michael, Lauer, Ulrich M. und Bitzer, Michael
(2007)
Epigenetic combination therapy as a tumor‐selective treatment approach for hepatocellular carcinoma.
Cancer 109 (10), S. 2132-2141.
Volltext nicht vorhanden.
, Vonthein, Reinhard, Wehrmann, Manfred, Gregor, Michael, Lauer, Ulrich M. und Bitzer, Michael
(2007)
Epigenetic combination therapy as a tumor‐selective treatment approach for hepatocellular carcinoma.
Cancer 109 (10), S. 2132-2141.
Volltext nicht vorhanden.
2006
Pathil, Anita, Armeanu, Sorin, Venturelli, Sascha, Mascagni, Paolo, Weiss, Thomas S. , Gregor, Michael, Lauer, Ulrich M. und Bitzer, Michael
(2006)
HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.
Hepatology 43 (3), S. 425-434.
2004
Armeanu, Sorin, Pathil, Anita, Venturelli, Sascha, Mascagni, Paolo, Weiss, Thomas S. , Göttlicher, Martin , Gregor, Michael, Lauer, Ulrich M. und Bitzer, Michael
(2004)
Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.
Journal of Hepatology 42 (2), S. 210-217.
Volltext nicht vorhanden.
, Göttlicher, Martin , Gregor, Michael, Lauer, Ulrich M. und Bitzer, Michael
(2004)
Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.
Journal of Hepatology 42 (2), S. 210-217.
Volltext nicht vorhanden.
2003
Armeanu, Sorin, Lauer, Ulrich M., Smirnow, Irina, Schenk, M., Weiss, Thomas S. , Gregor, M. und Bitzer, M.
(2003)
Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes.
Cancer Research 63 (10), S. 2369-2372.
Volltext nicht vorhanden.
, Gregor, M. und Bitzer, M.
(2003)
Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes.
Cancer Research 63 (10), S. 2369-2372.
Volltext nicht vorhanden.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707